CLEAR CELL ADENOCARCINOMA
Clinical trials for CLEAR CELL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for CLEAR CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial tests new combo to fight back when ovarian cancer returns
Disease control OngoingThis large, late-stage trial is for people whose ovarian, fallopian tube, or primary peritoneal cancer has returned after initial successful treatment. It aims to find the best way to control the cancer by testing whether adding a drug called bevacizumab to standard chemotherapy,…
Matched conditions: CLEAR CELL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for Tough-to-Treat ovarian cancers: immune therapy trial
Disease control OngoingThis study is testing whether two immunotherapy drugs, nivolumab alone or combined with ipilimumab, can help control recurrent clear cell ovarian, fallopian tube, and related cancers. It will enroll 46 patients whose cancer has returned after standard chemotherapy. The main goal …
Matched conditions: CLEAR CELL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Brown University • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC